More than 67,000 Americans are expected to be diagnosed with pancreatic cancer this year, but a new blood test is offering ...
A new study explains how pancreatic tumors use a sugar coating to hide from the immune system and shows that a newly developed antibody can restore immune responses in mice. Pancreatic cancer remains ...
Clinical Trials Arena on MSN
Immuneering progresses MAPK inhibitor in lung and pancreatic cancer
The biotech will now take atebimetinib to mid- and late-stage trials in NSCLC and pancreatic cancer, respectively.
The use of either MRI-guided stereotactic ablative body radiotherapy (SABR) or CT-guided percutaneous irreversible electroporation after standard FOLFIRINOX chemotherapy did not result in any ...
Pancreatic cancer accounts for about 8% of all cancer deaths. Ben Sasse says he expects to be one of them. Here's what to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback